Avience Biomedicals
Price Band
₹196 - ₹208
Lot Size
1,200 Shares
Issue Size
₹30.24 Cr
Fresh Issue
₹30.24 Cr
OFS
Nil (100% Fresh)
Registrar
AI Sentiment Score
Listing Price
₹395.20
vs Issue: ₹208 (+90.00%)
📅 IPO Timeline
✓
Open
Jun 18, 2026
✓
Close
Jun 20, 2026
✓
Allotment
Jun 22, 2026
✓
Refund
Jun 23, 2026
✓
Demat
Jun 23, 2026
✓
Listing
Jun 25, 2026
✨ AI Analysis & Prediction
🔒 Final Reconciled Estimate
Locked post-listing with actual debut performance
AI analysis will be available once the prospectus data is processed.
🎯 Objectives of the IPO
| Requirement / Purpose | Amount (₹ Cr) |
|---|---|
| Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh | ₹15.96 |
| Funding the working capital requirements of the Company | ₹8.25 |
| General Corporate Purpose | ₹6.03 |
📊 Key Financials
| Metric | 2024 | 2025 | Jan 2026 |
|---|---|---|---|
| Revenue (₹ Cr) | 24.37 | 45.97 | 41.94 |
| PAT (₹ Cr) | 2.14 | 7.23 | 5.74 |
Debt/Equity
0.97
📋 Live Subscription Status
QIB
0.00x
NII
0.00x
Retail
0.00x
Total
0.00x
🎯 Retail Allotment Probability
100% Odds
100% (Guaranteed 1 lot for all valid applications)
SEBI Rule: Under SEBI lottery allotment rules, applying for multiple lots under Retail does NOT increase your lottery odds. All valid retail applicants have identical 1-lot odds per PAN.
💼 Issue Structure & Reservation Quota
Capital Structure
₹30.2 Cr
Issue Size
Fresh (100%)
Reservation Quota
100%
Allocation
NII (50%)
Retail (50%)
QIB
0.00%
Retail
50.00%
NII
50.00%
📈 Shareholding & Anchor Lock-In
🔗 Important Links & Lead Managers
- Check Allotment StatusCheck Now →
- Registrar WebsiteVisit →
- Download DRHP ProspectusDownload PDF 📥
- Download RHP ProspectusDownload PDF 📥
Lead Managers / Merchant Bankers
This issue is managed by Hem Securities Ltd., and Share India Capital Services Pvt. Ltd.
Disclaimer: The information provided on this page is for educational and informational purposes only and does not constitute financial advice. IPO investments are subject to market risks. AI-generated analysis is based on publicly available data and may not be accurate. Grey Market Premium (GMP) is unofficial and highly speculative. Always consult a qualified financial advisor and read the DRHP/RHP carefully before making investment decisions.